Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study

Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease

(2011) Daijirou Akamatsu et al.   Journal of Atherosclerosis and Thrombosis

The immune system in atherosclerosis

(2011) Göran K Hansson et al.   NATURE IMMUNOLOGY

Doxycycline 40 mg Capsules (30 mg Immediate-Release/10 mg Delayed-Release Beads)

(2010) Kate McKeage et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Pharmacological modulation of vascular inflammation in atherothrombosis

(2010) Raffaele De Caterina et al.   Annals of the New York Academy of Sciences

Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)

(2010) Jack Caton et al.   PHARMACOLOGICAL RESEARCH

The natural history of aortic atherosclerosis: A systematic histopathological evaluation of the peri-renal region

(2009) R.A. van Dijk et al.   ATHEROSCLEROSIS

Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm

(2009) Jan H.N. Lindeman et al.   CIRCULATION

c-Jun N-Terminal Kinase 2 Deficiency Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction and Oxidative Stress

(2008) Elena Osto et al.   CIRCULATION

Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm

(2008) Jan H. N. Lindeman et al.   CLINICAL SCIENCE

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

(2008) Anthony J. Muslin   CLINICAL SCIENCE